TY - JOUR
T1 - Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease
AU - Fitze, Guido
AU - Cramer, Jakob
AU - Ziegler, Andreas
AU - Schierz, Mandy
AU - Schreiber, Matthias
AU - Kuhlisch, Eberhard
AU - Roesner, Dietmar
AU - Schackert, Hans K.
N1 - Funding Information:
This study was supported by Deutsche Forschungsgemeinschaft-grant FI 809/1-1. We thank the patients involved in this study; J Engert (Herne), T Erler (Cottbus), and P Küster (Münster) for providing samples from their patients; and Yvonne Kemnitz for technical assistance.
PY - 2002/4/6
Y1 - 2002/4/6
N2 - Background: Several genes, including the major susceptibility gene RET, have roles in development of Hirschsprung's disease. Results of genetic-linkage analysis of patients with familial disease with both long-segment and short-segment phenotypes have shown close linkage with the RET locus. We aimed to investigate whether both RET mutations and polymorphisms contribute to phenotype of Hirschsprung's disease. Methods: We looked at the coding region of all 21 exons of the RET proto-oncogene, including the flanking intronic sequences, by direct DNA sequencing in 76 caucasians from Germany with Hirschsprung's disease. Findings: 20 different mutations were detected in 18 patients. Mutations were under-represented in patients with a homozygous RET c135A/A genotype in association with short-segment phenotype. Short-segment phenotype also arose if the RET mutation was on the c135A allele; conversely, a RET germline mutation on the c135G allele resulted in long-segment phenotype, particularly in heterozygous c135G/A patients. Interpretation: These observations lend support to the idea that both RET alleles have a role in pathogenesis of Hirschsprung's disease, in a dose-dependent fashion. We also showed that the c135G/A polymorphism modifies the phenotype by a within-gene interaction between the c135A variant and a mutation.
AB - Background: Several genes, including the major susceptibility gene RET, have roles in development of Hirschsprung's disease. Results of genetic-linkage analysis of patients with familial disease with both long-segment and short-segment phenotypes have shown close linkage with the RET locus. We aimed to investigate whether both RET mutations and polymorphisms contribute to phenotype of Hirschsprung's disease. Methods: We looked at the coding region of all 21 exons of the RET proto-oncogene, including the flanking intronic sequences, by direct DNA sequencing in 76 caucasians from Germany with Hirschsprung's disease. Findings: 20 different mutations were detected in 18 patients. Mutations were under-represented in patients with a homozygous RET c135A/A genotype in association with short-segment phenotype. Short-segment phenotype also arose if the RET mutation was on the c135A allele; conversely, a RET germline mutation on the c135G allele resulted in long-segment phenotype, particularly in heterozygous c135G/A patients. Interpretation: These observations lend support to the idea that both RET alleles have a role in pathogenesis of Hirschsprung's disease, in a dose-dependent fashion. We also showed that the c135G/A polymorphism modifies the phenotype by a within-gene interaction between the c135A variant and a mutation.
UR - http://www.scopus.com/inward/record.url?scp=0037029395&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(02)08218-1
DO - 10.1016/S0140-6736(02)08218-1
M3 - Journal articles
C2 - 11955539
AN - SCOPUS:0037029395
VL - 359
SP - 1200
EP - 1205
JO - The Lancet
JF - The Lancet
SN - 0140-6736
IS - 9313
ER -